Articles By Ed Miseta
-
Patient Diversity Starts With Community Connections
12/19/2019
When it comes to clinical trials, the pharmaceutical industry still has a patient diversity problem. The face of patients in clinical trials is not representative of the face of America or the individuals projected to be most in need of the medications being developed.
-
Technology Advancements Spur Adoption Of Virtual Trials
11/27/2019
Virtual trials have been around for years, so why are they still met with skepticism? Clinical trial executives from Janssen and Astellas weigh in on this hot topic for 2020.
-
What Exactly Is A Virtual Clinical Trial?
11/21/2019
Oracle Health Sciences and the CNS Summit have released a research report on the use of virtual components (patient-facing technologies) in clinical trials. The findings are the result of focus group interviews and supplementary research with key stakeholders involved with clinical trials.
-
Former Novartis CEO: Cell And Gene Therapies Will Drive Innovation
11/19/2019
Joe Jimenez joined Novartis as division head of Consumer Health. A few months later, he was asked to run the pharmaceutical division. Shortly after his promotion to CEO, Novartis was the first company to pursue a CAR T therapy. Today, Jimenez marvels at the innovation taking place in the industry, and believes cell and gene therapies will drive future development.
-
Patient Diversity Starts With Community Connections
8/30/2019
When it comes to clinical trials, the pharmaceutical industry still has a patient diversity problem. The face of patients in clinical trials is not representative of the face of America.
-
Success In HIV Treatments Creates Additional Challenges For Drug Developers
7/1/2019
HIV drug developers have a whole new set of challenges, including making the regimens simpler better tolerated. In addition, since today’s patients can access these medicines through pharmacies, they no longer have the incentive to take part in clinical studies.
-
Regeneron Manages Clinical Costs In A Fast-Growing Organization
5/1/2019
Bari Kowal, VP and head of global clinical operations at Regeneron, says sponsors and CROs must partner to make clinical trial execution more efficient and cost-effective.
-
AbbVie Goes All-In On Wearables And Digital Technologies
5/1/2019
Three years ago, AbbVie decided to stop talking about using digital technologies in clinical trials and start actually using them. The company then began deploying wearables in three clinical trials.
-
CRO Leadership Awards Move To Primetime
5/1/2019
If you are looking for a CRO to help take your molecule through clinical trials and the process of gaining regulatory approval, who do you turn to? It’ not like there is an Angie’s List for CROs.
-
Master Trial Protocols: Better For Pharma, Better For Sites
2/1/2019
The primary benefit of master trial protocols for drug companies is the ability to concurrently evaluate multiple studies that may have different objectives, saving both time and money.